INTRODUCTION {#sec1-1}
============

The efficacy of clozapine in treatment-resistant schizophrenia is well documented. It is also useful in the management of psychotic symptoms of dementia but should be used with caution due to its broad side-effect profile.[@CIT1] The prevalence of ECG abnormalities in patients who had been using anti-psychotics other than clozapine was 13.6% which increased significantly to 31.1% after commencement of clozapine treatment.[@CIT2] Adverse cardiac effects such as tachycardia, hypotension and hypertension are the most common,[@CIT3] warranting stoppage in many patients.[@CIT4] Circulatory collapse, arrhythmias, myocarditis, cardiomyopathy, pericarditis and pericardial effusion are also known to occur.[@CIT5] Cardiac failure may develop secondary to myocarditis and cardiomyopathy. In a 10-year naturalistic study, clozapine-treated patients appear to be at risk for death from cardiovascular disease secondary to clozapine-associated medical disorders such as obesity, diabetes, hypertension, and hyperlipidaemia.[@CIT6] Sudden death in the initial phase of treatment due to hypersensitivity myocarditis has been reported.[@CIT7] A case of cardiac failure is described in which the classical features of myocarditis were absent.

THE CASE {#sec1-2}
========

M, a 73-year-old woman, was on treatment for dementia of the Alzheimer type with delusions (DSM-IV 290.12) for the past 3 years. As the psychotic symptoms did not respond to various antipsychotics, she was put on clozapine. Considering her age and the known adverse effects of the drug, a cardiology consultation was done on 13 December 2005. Clinical examination, ECG and echocardiogram were normal. Clozapine was started the next day at a dose of 12.5 mg/day, and gradually increased to 100 mg/day. On 5 January 2006 she developed breathlessness. Clinical examination showed signs of cardiac failure with sinus tachycardia and poor R wave progression in V1--V3. An echocardiogram revealed global left ventricular hypokinesia, mild left ventricular systolic dysfunction, a left ventricular ejection fraction of 40% and moderate mitral regurgitation. Clozapine was stopped. She responded to conventional antifailure measures.

DISCUSSION {#sec1-3}
==========

The temporal relationship between the introduction of clozapine and onset of cardiac failure suggests that the drug was responsible. However, she could have had independent age-related myocardial dysfunction. The classical features of myocarditis were absent. The maximum pulse rate in our patient was 92/min whereas in a recent case report[@CIT8] it was 130/min with features such as chest pain and flu-like symptoms---generalized bodyache, nasal congestion, sore throat, fever and eosinophilia. Cardiomegaly is a feature of dilated cardiomyopathy which occurs as a result of myocarditis. However, our patient had no cardiomegaly.

The clinical features of myocarditis are varied. The spectrum includes asymptomatic patients who may have electro-cardiographic abnormalities; patients with signs and symptoms of clinical heart failure and ventricular dilatation; and patients with symptoms of fulminant heart failure and severe left ventricular dysfunction, with or without cardiac dilatation.[@CIT9] Though the risk of potentially fatal myocarditis or cardiomyopathy with clozapine is estimated to be as low as 0.015%--0.188%,[@CIT10] it is suggested that extreme caution should be exercised when using the drug, especially in the elderly.
